NEXGEL, Inc. (NASDAQ:NXGL) CEO Adam R. Levy Sells 4,000 Shares of Stock

NEXGEL, Inc. (NASDAQ:NXGL) CEO Adam R. Levy sold 4,000 shares of the stock in a transaction on Tuesday, April 1st. The stock was sold at an average price of $3.01, for a total value of $12,040.00. Following the completion of the sale, the chief executive officer now owns 370,284 shares in the company, valued at approximately $1,114,554.84. The trade was a 1.07 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

NEXGEL Trading Down 5.3 %

NASDAQ NXGL opened at $2.85 on Thursday. The stock has a market cap of $19.35 million, a PE ratio of -4.91 and a beta of 0.62. NEXGEL, Inc. has a 12 month low of $1.84 and a 12 month high of $5.10. The company’s 50-day moving average price is $3.16 and its 200-day moving average price is $3.28. The company has a current ratio of 1.51, a quick ratio of 0.93 and a debt-to-equity ratio of 0.19.

NEXGEL (NASDAQ:NXGL) last issued its earnings results on Monday, March 24th. The company reported ($0.08) EPS for the quarter, topping analysts’ consensus estimates of ($0.10) by $0.02. The business had revenue of $3.04 million for the quarter, compared to the consensus estimate of $2.99 million. NEXGEL had a negative net margin of 52.60% and a negative return on equity of 71.19%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Geode Capital Management LLC raised its position in NEXGEL by 5.8% during the 4th quarter. Geode Capital Management LLC now owns 60,142 shares of the company’s stock valued at $268,000 after purchasing an additional 3,302 shares in the last quarter. Virtu Financial LLC purchased a new position in shares of NEXGEL during the fourth quarter valued at $48,000. IFP Advisors Inc purchased a new position in shares of NEXGEL during the fourth quarter valued at $49,000. Two Sigma Securities LLC purchased a new stake in NEXGEL in the fourth quarter worth about $54,000. Finally, Renaissance Technologies LLC lifted its stake in NEXGEL by 456.4% in the fourth quarter. Renaissance Technologies LLC now owns 158,331 shares of the company’s stock worth $706,000 after acquiring an additional 129,876 shares during the period. Institutional investors own 2.21% of the company’s stock.

NEXGEL Company Profile

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.